Bing-Hsien Liu

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles

M. Chiu, Shieh-Yueh Yang, H. Horng, 2016, Journal of Nanobiotechnology.

Nannoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease - A cross-validation study.

M. Chiu, Shieh-Yueh Yang, S. Yan, 2020, Nanomedicine : nanotechnology, biology, and medicine.

Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical use

Shieh-Yueh Yang, Kai-Wen Huang, Che-Chuan Yang, 2014, Journal of Nanobiotechnology.

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes

M. Chiu, Shieh-Yueh Yang, H. Horng, 2018, Front. Aging Neurosci..

Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.

M. Chiu, Shieh-Yueh Yang, Che-Chuan Yang, 2018, Journal of Alzheimer's disease : JAD.

Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases

Sung-Chun Tang, J. Jeng, M. Chiu, 2017, Scientific Reports.

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease

Ming-Jang Chiu, Chin-Hsien Lin, Jen-Jie Chieh, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

A Novel Detection Platform for Shrimp White Spot Syndrome Virus Using an ICP11-Dependent Immunomagnetic Reduction (IMR) Assay

Jui-Feng Chang, Ming-Hung Hsu, Yun-Tsui Chang, 2015, PloS one.